NLRP3 Inflammasome Signaling Platform as New Pharmacological Target for Metaflammation

Journal Title: Diabetes Research – Open Journal - Year 2017, Vol 3, Issue 1

Abstract

Metaflammation is a metabolic inflammatory state characterized by chronic, lowgrade inflammatory response initiated by excess nutrients in metabolic cells.1 The inflammatory signaling conducted by the metabolic cell eventually causes activation of specialized immune cells and leads to an unresolved inflammatory response within the tissue.2 The high level of coordination of inflammatory and metabolic pathways is highlighted by the overlapping biology and function of macrophages and adipocytes in obesity. Preadipocytes under some conditions can exhibit phagocytic and antimicrobial properties and appear to even be able to differentiate into macrophages in the right environment, which suggests a potential immune role for preadipocytes. Furthermore, macrophages and adipocytes co-localize in white adipose tissue in obesity. Macrophages in adipose tissue are likely to contribute to the production of inflammatory mediators either alone or in concert with adipocytes, which suggests a potentially important influence of macrophages in promoting insulin resistance. Besides macrophages, obesity is associated with aberrant expansion of other leukocytes (T-cells, B-cells, eosinophils, neutrophils and mast cells) in adipose tissue that contribute to chronic inflammation. In particular, the increased neutrophils lead to a rise of myeloperoxidase (MPO) activity, a marker of neutrophil infiltration, in the damaged tissue during inflammation.3Despite the role of meta-inflammation, in promoting metabolic diseases, including obesity and insulin resistance, is well known,4 from a therapeutic perspective, only limited experience is available regarding the inhibition of specific inflammatory pathways activated by the metabolic, biochemical and haemodynamic derangements known to exist in CMD.

Authors and Affiliations

Massimo Collino

Keywords

Related Articles

Regulatory T-Cells in Treatment of Type-1 Diabetes: Types and Approaches

Regulatory T-cells (Tregs) play important role in regulation of immune responses to self-antigens. Alterations in frequency and function of Tregs have been reported in Type 1 Diabetes (T1D) subjects. Tregs have the poten...

A Multicenter Italian Survey on Diabetes Care Units Reveals a Somewhat Slow Attitude in Treatment Guideline Implementation: Are We Dealing With Therapeutic Inertia?

Aim: Current guidelines suggest pursuing optimal metabolic management ever since the onset of type 2 diabetes mellitus (T2DM). Nevertheless, over 50% Italian patients fail to meet expected metabolic targets. The aim of o...

Associations of Waist-to-Height Ratio with Various Emotional and Irregular Eating, and Making Environment to Promote Eating in Japanese Adults: The Saku Cohort Study

Objective: The waist-to-height ratio (WHtR) has started gaining attention as a measure of abdominal obesity. While the associations between various eating behaviors and high BMI or obesity or overweight determined by BMI...

More Significant Life for Diabetic Patients in the Perspectives of Anti-Aging

For the patients with diabetes, basal daily lifestyle would be considered in the light of meal, exercise, rest, alcohol intake, smoking and oral health. These six factors are from the concept as a basic direction of “Hea...

Increasing Adherence to the Diabetes Regimen: An Occupational Therapy Perspective

Recognizing the epidemic of diabetes in the United States, the Centers for Disease Control projected that as many as one third of the population will have diabetes by 2050, without a concerted effort to change the lifest...

Download PDF file
  • EP ID EP550202
  • DOI 10.17140/DROJ-3-e008
  • Views 130
  • Downloads 0

How To Cite

Massimo Collino (2017). NLRP3 Inflammasome Signaling Platform as New Pharmacological Target for Metaflammation. Diabetes Research – Open Journal, 3(1), 1-3. https://www.europub.co.uk/articles/-A-550202